BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7055012)

  • 1. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors.
    Aellig WH
    Adv Neurol; 1982; 33():321-4. PubMed ID: 7055012
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects on arterial receptors of ergot derivatives used in migraine.
    Müller-Schweinitzer E; Fanchamps A
    Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Hardebo JE; Edvinsson L; Owman C; Svendgaard NA
    Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serotonin agonists and antagonists in migraine].
    Ollat H
    Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonists and antagonists of vascular receptors.
    Saxena PR
    Adv Neurol; 1982; 33():309-14. PubMed ID: 7034489
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serotonin and antiserotonergic agents].
    Bourin M
    Rev Prat; 1990 Jun; 40(18):1711-3. PubMed ID: 2371526
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.
    Müller-Schweinitzer E
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):41-4. PubMed ID: 1004641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in serotonin and catecholamines vascular reactivity during migraine attack.
    Franchi G; Anselmi B; Michelacci S
    Res Clin Stud Headache; 1970; 3():304-9. PubMed ID: 5527211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Test of venoconstriction in humans; an improved technic for quantitative evaluation of venous spasm].
    Del Bianco PL; Sicuteri F
    Boll Soc Ital Biol Sper; 1975 Jul; 51(14):883-8. PubMed ID: 1218108
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man.
    Aellig WH
    Eur J Clin Pharmacol; 1983; 25(6):759-62. PubMed ID: 6662174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of migraine and ergot upon reflex vasodilatation to radiant heating.
    Macmillan AL; Hockaday J
    Bibl Anat; 1967; 9():343-7. PubMed ID: 6029885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Classification, pathogenesis and drug therapy of migraine and related forms of headache].
    Fanchamps A
    Med Welt; 1975 Aug; 6(35):1518-23. PubMed ID: 241000
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
    Dlohozková N; Metys J; Valchár M; Soucek R
    Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
    [No Abstract]   [Full Text] [Related]  

  • 14. The animal pharmacology of drugs used in the treatment of migraine.
    Fozard JR
    J Pharm Pharmacol; 1975 May; 27(5):297-321. PubMed ID: 239131
    [No Abstract]   [Full Text] [Related]  

  • 15. [New aspects of headache treatment].
    Pichler E
    Monatsschr Ohrenheilkd Laryngorhinol; 1966 Dec; 100(12):544-50. PubMed ID: 16114452
    [No Abstract]   [Full Text] [Related]  

  • 16. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
    Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects].
    Marco Igual M
    Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545
    [No Abstract]   [Full Text] [Related]  

  • 18. Basic mechanisms of antimigraine drugs.
    Fozard JR
    Adv Neurol; 1982; 33():295-307. PubMed ID: 7034488
    [No Abstract]   [Full Text] [Related]  

  • 19. The way to serotonergic use and abuse in migraine.
    Nicolodi M; Del Bianco PL; Sicuteri F
    Int J Clin Pharmacol Res; 1997; 17(2-3):79-84. PubMed ID: 9403359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between venoconstrictor effects of sumatriptan and ergotamine in migraine patients.
    Panconesi A; Anselmi B; Curradi C; Perfetto F; Piluso A; Franchi G
    Headache; 1994 Apr; 34(4):194-7. PubMed ID: 8014033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.